BioBridge Ltd, the UK-based bioscience innovation consultancy, announces the start of a new working relationship with Osprey Consultants LLC, a US-based animal health consultancy specialising in veterinary medicine product development and commercialisation. BioBridge and Osprey will assist each other in providing services for their respective clients.
Osprey’s founder, Dr. William Symington, has, similar to BioBridge’s Meredith Lloyd-Evans, long-term experience in the animal health industry. His 40 years of experience has covered all domesticated species and all key global regions.…
Coventry, UK, 25th June 2019 / Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019. Nigel Davis, the current CEO, will remain with the Company as Chief Business Officer.
Medherant has completed two Phase I clinical studies with an Ibuprofen TEPI Patch and is discussing its further development with potential commercial partners whilst it focuses on the development of patch products to treat…
Collaboration will initially accelerate C4X Discovery’s Parkinson’s disease drug discovery pipeline
Cambridge, UK, 25 June, 2019: PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc (AIM: C4XD), a pioneering drug discovery company, today announced they have signed a neurodegeneration drug discovery collaboration agreement. Combining the two companies’ technology platforms to validate novel targets, the initial focus will be on Parkinson’s disease.
Under the terms of the agreement, PhoreMost’s next-…
With two acquisitions complete this year, Entrust Resource Solutions are now creating new jobs across the UK by adding a specialist Resourcing Team to their business.
Entrust Resource Solutions recently announced an ambitious growth and acquisition strategy. This started with the addition of two resourcing consultancies to their portfolio, with Horton International (UK) and SCI Search and Selection joining Entrust People. To keep up with their rate of growth and better support their team, the business is now creating a new Resourcing Team.
The Resourcing Team will primarily support the…
ScreenIn3D, a partner of AMSBIO, has received a share of the £1 million plus prize pot and will receive ongoing support from partners of Scottish Edge - a respected regional business support agency.Scottish EDGE (https://www.scottishedge.com/) runs a competition aimed at identifying and supporting Scotland’s up-and-coming, innovative, high-growth potential entrepreneurial talent. The winning businesses for the latest Round 14 awards came from 37 multisector finalists, shortlisted from more than 280 applicants, who pitched their business idea live at Glasgow’s Technology and Innovation Centre…
Bristol-Myers Squibb will maintain strategic presence in Italy through ongoing development and commercialization of new medicines
Catalent will continue to manufacture products for Bristol-Myers Squibb while offering other customers access to state-of-the-art sterile biologics fill/finish and oral solids manufacturing and packaging platforms
(NEW YORK and SOMERSET, N.J., June 19, 2019) – Bristol-Myers Squibb Company (NYSE:BMY) and Catalent, Inc. (NYSE: CTLT), today announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing…
Reading Scientific Services Ltd (RSSL) is tripling the size of its pharmaceutical microbiology laboratory with the opening of a new, state-of-the-art facility in Wokingham. The move follows sustained market demand for the consultancy’s microbiological analysis services. It not only provides the operational space to significantly increase capacity, but also signals a commitment to the future expansion of test methods and staff levels.
“We have experienced tremendous growth over recent years and have simply outgrown the existing laboratory at our head office in Reading. This purpose-designed…
San Diego, USA and Cambridge, UK, 12 June, 2019: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and PhoreMost Limited today announced the signing of a research collaboration agreement between Ligand’s subsidiary Vernalis and PhoreMost on an undisclosed novel oncology target.
PhoreMost has identified and validated the target using its next-generation SITESEEKER® phenotypic screening technology. Ligand will now apply its Vernalis Design Platform (VDP) to design small molecule inhibitors against the target, to help rapidly progress compounds through hit-to-lead and lead optimization stages.…
An Innovation Day focused on the future of mobility has enabled leading global automotive supplier Magna International to make important connections with researchers, start-ups and companies in and around Cambridge.
Keen to find out about the latest developments, with a view to adding to its portfolio of products, Magna - which has 348 manufacturing operations and almost 100 product development, engineering and sales centres in 28 countries - partnered for a second time with Cambridge Network to identify likely contacts in the region.
Cambridge Network organised an Innovation Day at Cambridge…
The increasing popularity of the human microbiome in biotech has become a source of scientific and investor excitement in recent years. Microbiomes, or the genes of a community of microbial cells (or microbiota) which the body is host to, have unexpected benefits and implications for overall health, from regulating the immune system, to influencing conditions such as obesity, diabetes, cancer and aging. While it is in the gut that humans have the most diverse and densely populated microbiota, their influence and presence in other parts of the body has made the microbiome comparable to “a…